发明名称 Splice-region antisense composition and method
摘要 Antisense compositions targeted against an mRNA sequence coding for a selected protein, at a region having its 5′ end from 1 to about 25 base pairs downstream of a normal splice acceptor junction in the preprocessed mRNA, are disclosed. The antisense compound is RNase-inactive, and is preferably a phosphorodiamidate-linked morpholino oligonucleotide. Such targeting is effective to inhibit natural mRNA splice processing, produce splice variant mRNAs, and inhibit normal expression of the protein.
申请公布号 US8895722(B2) 申请公布日期 2014.11.25
申请号 US201313859518 申请日期 2013.04.09
申请人 Sarepta Therapeutics, Inc. 发明人 Iversen Patrick L.;Hudziak Robert
分类号 C07H21/04;C07H21/02;A61K48/00 主分类号 C07H21/04
代理机构 Seed IP Law Group PLLC 代理人 Seed IP Law Group PLLC
主权项 1. An antisense compound composed of a 2′-O-methyl modified backbone and a base sequence of 12 to 25 nucleotide bases which is complementary to a target region within one exon of multiple exons of a preprocessed mRNA encoding a human protein, wherein the 5′-end of the target region is 12 bases downstream of a normal splice acceptor site in said preprocessed mRNA.
地址 Corvallis OR US